series-b
Stage
1
Investors
About
CymaBay Therapeutics is a clinical-stage biopharmaceutical company focused on the development of therapeutics for the treatment of chronic liver and other serious diseases.
Explore CymaBay Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.